VEGFA and small cell lung carcinoma: In an autochthonous mouse model of SCLC, the treatment outcome of mice treated with combined anti-PD-L1 and anti-VEGF targeted therapy is significantly successful compared to anti-VEGF and anti-PD-L1 monotherapy.